Published in Indian J Lepr on April 01, 1989
Can primary health centres offer care to the leprosy-disabled after integration with general health services?--a study in rural India. Lepr Rev (2008) 1.38
Relapse of multibacillary leprosy after rifampin and ofloxacin treatment for 28 days; a case report. Int J Lepr Other Mycobact Dis (1998) 1.38
Tonsillolith: a case report. J Oral Maxillofac Surg (2001) 1.11
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med (1998) 1.08
A study of mono-neuritic lesions in a leprosy clinic. Lepr India (1976) 1.07
Rapid differentiation of Mycobacterium bovis and Mycobacterium tuberculosis based on a 12.7-kb fragment by a single tube multiplex-PCR. Vet Microbiol (2005) 1.03
An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993. Indian J Lepr (1996) 1.02
Modifications in biphasic liquid-scintillation vial system for radiometry. J Nucl Med (1980) 1.01
Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid (1994) 0.98
Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine (1990) 0.96
Thalidomide in leprosy--study of 94 cases. Indian J Lepr (1987) 0.96
Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Int J Rad Appl Instrum B (1986) 0.93
Socioeconomics of a global leprosy eradication programme. Pharmacoeconomics (1998) 0.91
Isolation of environment-derived Mycobacterium leprae from soil in Bombay. Lepr Rev (1986) 0.89
Some interesting disease combinations--report on two cases. Lepr India (1976) 0.87
Disappearance rate of endogenously radioiodinated thyroglobulin and thyroxine after radioiodine treatment. Cancer (1982) 0.87
Penile and scrotal lesions in leprosy: case reports. Lepr Rev (1989) 0.86
Involvement of scalp in leprosy--a case report. Indian J Lepr (1986) 0.86
Decompression of the ulnar and median nerves in leprous neuritis. Lepr Rev (1968) 0.86
Brain metastases in well-differentiated carcinoma of the thyroid. Tumori (1997) 0.86
Modified rapid radiometric method for detection of Mycobacterium tuberculosis from sputum samples. Int J Nucl Med Biol (1985) 0.84
The simultaneous inoculation of Mycobacterium leprae and M. intracellulare into nude mice: development of cutaneous leproma and accelleration of foot pad swelling. Indian J Lepr (1988) 0.82
A rapid radiometric method for detection of M. tuberculosis: optimization of experimental conditions. Int J Nucl Med Biol (1984) 0.81
Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy. Int J Lepr Other Mycobact Dis (2003) 0.80
Reduction in caseload after multidrug therapy in an urban leprosy control programme--a retrospective study in Bombay. Lepr Rev (1991) 0.80
Development of an affinity ligand for purification of alpha 2-adrenoceptors from human platelet membranes. J Med Chem (1984) 0.80
A study of standardized regimens of steroid treatment in reactions in leprosy at a referral centre. Indian J Lepr (2012) 0.79
Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856. J Pharmacol Exp Ther (1991) 0.78
Soluble adhesion molecules in sera of patients with leprosy: levels of soluble intercellular adhesion molecule-1 (sICAM-1) rapidly decrease during multi-drug therapy. Clin Exp Immunol (1996) 0.78
Childhood leprosy--study of prevalence rates and clinical aspects through surveys in Bombay. Lepr India (1976) 0.78
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. Bioorg Med Chem Lett (2001) 0.78
Can urban health posts manage leprosy detection and treatment after integration with general health services?--A study in Bombay. Lepr Rev (2008) 0.77
'Wall Journal' on leprosy--a novel method to educate medical students. Lepr Rev (2000) 0.77
Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation. J Med Chem (1994) 0.77
Effect of chronic treatment with amlodipine in non-insulin-dependent diabetic rats. Pharmacol Res (1998) 0.76
Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions. Int J Lepr Other Mycobact Dis (1997) 0.76
alpha-Adrenergic agents. 2. Synthesis and alpha 1-agonist activity of 2-aminotetralins. J Med Chem (1982) 0.76
Total synthesis of the macrolide, (R,S)-zearalanone. J Med Chem (1973) 0.76
Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification. Acta Endocrinol (Copenh) (1981) 0.75
Relapse in leprosy. Indian J Lepr (1996) 0.75
Alpha-adrenergic agents. 1. Direct-acting alpha 1 agonists related to methoxamine. J Med Chem (1981) 0.75
Relapse after MDT in MB cases. Indian J Lepr (1996) 0.75
Editorials, September 1997 by W. C. S. Smith and P. Fine & D. K. Warndorff. Lepr Rev (1998) 0.75
Epidemiology of leprosy. Int J Lepr Other Mycobact Dis (2004) 0.75
Quality service to leprosy patients using mobile phones and pagers. Lepr Rev (2009) 0.75
Women workers in leprosy. Indian J Lepr (1996) 0.75
Effect of thyroxine on lymphocyte stimulation. Indian J Cancer (1977) 0.75
Task-oriented short-term training to contract leprosy workers in a national leprosy eradication programme. Lepr Rev (1995) 0.75
Iodinated thyrolipids: their possible role in homonogenesis. Acta Endocrinol (Copenh) (1973) 0.75
Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Int J Lepr Other Mycobact Dis (1999) 0.75
Whither "world without leprosy"? Indian J Dermatol Venereol Leprol (2006) 0.75
Effect of thionamides on adenyl cyclase activity and phospholipogenesis in rat thyroids. Biochem Pharmacol (1978) 0.75
Interpretation of data on monolesion leprosy case vs total new case detection rate. Lepr Rev (1995) 0.75
Dormancy, drug resistance or dependency; some thoughts to ponder. Int J Lepr Other Mycobact Dis (1996) 0.75
Serum markers of treatment success in leprosy. Int J Lepr Other Mycobact Dis (1999) 0.75
Social background of leprosy patients in Bombay. Indian J Lepr (1995) 0.75
The use of an amino acid as a precursor of a bioactive metabolite in combatting an infectious disease: The efficacy of a tryptophan-enriched diet in the treatment of leprosy. Amino Acids (1992) 0.75
Involvement of non-allopathy medical colleges in case detection. Lepr Rev (1998) 0.75
Single-dose treatment for paucibacillary leprosy; field implications. Int J Lepr Other Mycobact Dis (1999) 0.75
Negativity rate in multibacillary leprosy after MDT. Indian J Lepr (1992) 0.75
Hidden sources of infection in unapproachable areas. Indian J Lepr (1997) 0.75
Can cost of leprosy case detection in urban areas be further reduced? Int J Lepr Other Mycobact Dis (2001) 0.75
Thirteen years of follow-up of 100 smear positive leprosy cases after completion of multidrug therapy. Indian J Lepr (1996) 0.75
Detection of smear positive cases--need of the hour. Indian J Lepr (1995) 0.75
Effect of actinomycin D on the uptake of radioiodine by thyroidal and extrathyroidal tissues. II. Biochem Pharmacol (1970) 0.75
Leprosy elimination campaign in a metropolitan leprosy project, Bombay, India. Lepr Rev (1999) 0.75
A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy. Int J Lepr Other Mycobact Dis (1997) 0.75
Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations. Int J Lepr Other Mycobact Dis (2002) 0.75
Humoral response to nerve glycolipid antigen in sera of leprosy patients. Int J Lepr Other Mycobact Dis (1992) 0.75
Leprosy case detection through community volunteers--a low cost strategy. Int J Lepr Other Mycobact Dis (2001) 0.75
Survey of leprosy in unapproachable and uncovered areas. Indian J Lepr (2000) 0.75
Task-oriented training of primary health care personnel in leprosy case detection--an assessment. Indian J Lepr (1995) 0.75
Iodinated thyrolipids. Acta Endocrinol (Copenh) (1972) 0.75
Granuloma regression after fixed duration therapy. Indian J Lepr (1999) 0.75
Leprosy survey in industries in Bombay. Indian J Lepr (1989) 0.75
Effect of Prothionamide in Leprosy Clinico-bacteriological Observations. Indian J Dermatol Venereol Leprol (2017) 0.75
Relapsing multibacillary leprosy--a new dimension to transmission in urban areas. Int J Lepr Other Mycobact Dis (2001) 0.75
Proportion of beneficiaries vs relapse in MDT programme. Lepr Rev (1995) 0.75
Training of health posts personnel in urban leprosy programme--a preliminary report. Indian J Lepr (1991) 0.75
Has the term "elimination" outlived its utility? Int J Lepr Other Mycobact Dis (2005) 0.75
Clinical, histopathological and bacteriological investigations in two cases of relapse following ROM treatment. Lepr Rev (2001) 0.75
Immunotherapy in clinical practice--an evaluation. Indian J Dermatol Venereol Leprol (2007) 0.75
Cost-effective management of leprosy by involving interns. Lepr Rev (2008) 0.75
Leprosy control within urban primary health care. Indian J Lepr (1990) 0.75
Experience of multidrug therapy blister-calendar packs in an urban leprosy control programme in Bombay. Lepr Rev (1991) 0.75
The Dharavi story--saga of LECs over 2 decades. Lepr Rev (1999) 0.75
Multi centre evaluation of "DDS tile test" for detection of dapsone in urine. Indian J Lepr (1989) 0.75
Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study. Indian J Lepr (1989) 0.75
Operational aspects of FDT in leprosy. Indian J Lepr (1997) 0.75
Analysis of competitive examination in leprosy for medical undergraduates in Bombay over 22 years old. Lepr Rev (1994) 0.75
Epidemiological studies in children of a low-endemic region, a high-endemic region, and dwellers of a leprosy colony: evaluation of anti-ND-BSA antibodies and lepromin response. Int J Lepr Other Mycobact Dis (1994) 0.75
Separation of cyclic-3',5'-adenosine monophosphate from other adenine nucleotides. J Chromatogr (1969) 0.75
Single-dose treatment for paucibacillary leprosy; clinical problems and management. Int J Lepr Other Mycobact Dis (1999) 0.75
Single-dose treatment for single lesion leprosy; histopathological observations. Int J Lepr Other Mycobact Dis (2000) 0.75
Impact of MDT on leprosy prevalence as judged by surveys in the "megacity" of Mumbai. Indian J Lepr (1999) 0.75
An assessment of performance 'contract leprosy workers' in a National Leprosy Eradication Programme. Lepr Rev (1997) 0.75
Modulan grip-aids for leprosy patients. Int J Lepr Other Mycobact Dis (1992) 0.75
Effect of actinomycin D on the uptake of radioiodine by thyroidal and extrathyroidal tissues. I. Biochem Pharmacol (1969) 0.75